These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 6853697)

  • 1. A review of the etiology of multiple sclerosis.
    Vella V
    Ital J Neurol Sci; 1984 Dec; 5(4):347-56. PubMed ID: 6099345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of serum and plasma components in patients with multiple sclerosis.
    Ford HC
    Clin Biochem; 1985 Feb; 18(1):3-13. PubMed ID: 3886192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes in serum and cerebrospinal fluid of multiple sclerosis patients and patients with other neurological diseases.
    Salmi A; Ziola B; Reunanen M; Julkunen I; Wager O
    Acta Neurol Scand; 1982 Jul; 66(1):1-15. PubMed ID: 7113673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in serum and in cerebrospinal fluid of patients with multiple sclerosis. Characterization and correlation with the clinical course.
    Procaccia S; Lanzanova D; Caputo D; Ferrante P; Papini E; Gasparini A; Colucci A; Bianchi M; Villa P; Blasio R
    Acta Neurol Scand; 1988 May; 77(5):373-81. PubMed ID: 3046225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
    Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
    Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune complexes in patients with multiple sclerosis. A longitudinal study of serum and CSF by C1q and platelet binding tests.
    Arnadottir T; Kekomäki R; Lund GA; Reunanen M; Salmi AA
    J Neurol Sci; 1982 Sep; 55(3):273-83. PubMed ID: 6982312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.
    Kasai N; Pachner AR; Yu RK
    J Neurol Sci; 1986 Aug; 75(1):33-42. PubMed ID: 2427659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immune complexes in multiple sclerosis by an antigen-specific immune complex radioimmunoassay.
    Lund GA; Arnadottir T; Hukkanen V; Reunanen M; Salmi A
    J Neuroimmunol; 1983 Jun; 4(3):253-64. PubMed ID: 6853697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to myelin antigens in multiple sclerosis.
    Lisak RP; Zweiman B; Burns JB; Rostami A; Silberberg DH
    Ann N Y Acad Sci; 1984; 436():221-30. PubMed ID: 6085227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer.
    Rossen RD; Reisberg MA; Singer D; Suki WN; Duffy J; Hersh EM; Schloeder FX; Hill LL; Eknoyan G
    Medicine (Baltimore); 1979 Jan; 58(1):65-79. PubMed ID: 154003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current theories on the biochemical and immunological aspects of demyelination in multiple sclerosis].
    Cendrowski W
    Postepy Hig Med Dosw; 1981; 35(2):159-75. PubMed ID: 6460993
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?
    Podbielska M; Hogan EL
    Mult Scler; 2009 Sep; 15(9):1011-29. PubMed ID: 19692432
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.